Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...
A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new ...
University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...
Astellas Pharma’s strong pipeline and revenue growth support a positive outlook. See why ALPMF stock is a "Buy," driven by ...
Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...
Frazier Life Sciences launched Callio Therapeutics, a cancer startup headquartered in Seattle and Singapore. Frazier led ...
Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
Purple Biotech's growing intellectual property portfolio for NT219 in combination with anti-cancer standard-of-care therapies ...
Geoffrey Shouse, DO, PhD, discusses the growing interest in bispecific antibodies within the field of oncology.
In this week’s edition of the biotech bi-weekly, learn more about CRAIC technologies’ 5D Spectral Surface Mapping solution, ...